Point72 Asset Management
INBX

Point72 Asset Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Point72 Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-319,500
Closed -$8.29M – 3015
2023
Q2 		$8.29M Buy
319,500
+80,381
+34% +$1.88M 0.02% 647
2023
Q1 		$4.51M Sell
239,119
-513,381
-68% -$11.9M 0.01% 793
2022
Q4 		$18.5M Buy
752,500
+295,400
+65% +$8.68M 0.06% 354
2022
Q3 		$8.21M Sell
457,100
-242,000
-35% -$4.36M 0.03% 564
2022
Q2 		$7.93M Buy
+699,100
New +$10.3M 0.03% 573

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Point72 Asset Management's INBX Position: Q3 2023 in Review

Point72 Asset Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2023, closing a stake of 319,500 shares — an estimated $8.29M sold.

Point72 Asset Management first reported a position in INBX in Q2 2022 and held it in 5 quarters. The position peaked at $18.5M in Q4 2022. 111 funds tracked by Wall St. Rank hold INBX as of Q3 2023.

  • Point72 Asset Management reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 319,500 Inhibrx, Inc. Common Stock shares in Q3 2023, an estimated $8.29M.
  • Point72 Asset Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Point72 Asset Management's Inhibrx, Inc. Common Stock position peaked at $18.5M in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.